Table 1.
Stent characteristics of three bioresorbable scaffolds.
| Characteristics | AMS-1 | Absorb GT 1 | MOTIV |
| Scaffold material | Magnesiµm alloy | PLLA | Tyrocore |
| Drug coating | None | Everolimus+PDLLA | Sirolimus+Tyrocore |
| Strut thickness | 3.0 mm, 165 µm | 2.5 mm, 150 µm | 2.5 mm, 95 µm |
| 3.5 mm, 165 µm | 3.0 mm, 150 µm | 3.0 mm, 105 µm | |
| 3.5 mm, 150 µm | 3.5 mm, 115 µm | ||
| Crossing profile | 1.5 mm | 1.44 mm | 1.3 mm |
| Delivery | Single-step inflation | Muti-step inflation | Single-step inflation |
| Radial strength | 0.17 N/mm | 0.14 N/mm | 0.22 N/mm |
| Recoil | 8% | 2.3% | 2.0% |
| Max expansion over nominal | 0.6 mm | 0.5 mm | 0.75 mm, 2.5–3.0 mm |
| 0.5 mm, 3.5 mm | |||
| Resorption profile | At least 4 months | Loss of mechanical support in 18 months | Vessel uncaged in 12 months |
| Resorption in 36 months | Resorption in 48 months |
AMS, absorbable metal stent; PLLA, poly L-lactic acid; PDLLA, poly D, L-lactic acid.